SCHEMBL29411428

SCHEMBL29411428

Cc1cc2ncc(C(=O)NCCCc3ccc(-c4ccccc4F)cc3)cn2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
POLB P06746 3/20 0.42
KDM4E B2RXH2 2/20 0.42
HIF1A Q16665 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
RAB9A P51151 3/20 0.41
APOBEC3A P31941 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PPARG P37231 1/20 0.41
NPC1 O15118 2/20 0.40
NAMPT P43490 1/20 0.40
AGTR1 P30556 1/20 0.40
CNR1 P21554 1/20 0.40
MAPT P10636 2/20 0.40
PDE4B Q07343 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
MAPKAPK2 P49137 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045521 1.00 LMNA (0.43) LMNAPOLBKDM4EHIF1ASMN1; SMN2
SCHEMBL29411420 0.87 FYN (0.40) LMNAHIF1ACYP3A4
SCHEMBL21045108 0.87 FYN (0.40) LMNAHIF1ACYP3A4
SCHEMBL21045178 0.83 KDM4E (0.55) POLBKDM4EHIF1ARAB9APPARG
SCHEMBL29411410 0.83 KDM4E (0.55) POLBKDM4EHIF1ARAB9APPARG
SCHEMBL21045331 0.82 HIF1A (0.49) POLBKDM4EHIF1ASMN1; SMN2RAB9A
SCHEMBL29411657 0.82 HIF1A (0.49) POLBKDM4EHIF1ASMN1; SMN2RAB9A
SCHEMBL21045247 0.81 LMNA (0.57) LMNAPOLBKDM4EHIF1ASMN1; SMN2
SCHEMBL29411512 0.81 LMNA (0.57) LMNAPOLBKDM4EHIF1ASMN1; SMN2
SCHEMBL21045478 0.81 LMNA (0.39) LMNAPOLBKDM4ESMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188035-A1 TUBULIN INHIBITORS LIN BIOSCIENCE LLC (US) 2025-06-12 US disclosed
US-12247010-B2 Tubulin inhibitors LIN BIOSCIENCE INC. (TW) 2025-03-11 US disclosed
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089539-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB LMNA 2547/4885POLB 350/4885KDM4E 4032/4885
US-12247010-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB LMNA 2547/4885POLB 350/4885KDM4E 4032/4885
US-20250188035-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB LMNA 2547/4885POLB 350/4885KDM4E 4032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.